Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Passaro A, Al Bakir M, Hamilton EG, Diehn M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. · 2024
Read Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. by Passaro A, Al Bakir M, Hamilton EG, Diehn M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7616034.txt.
Description
Passaro and co-authors review cancer biomarkers and their role in personalized treatment of solid tumors. Biomarkers have reshaped how cancer care is planned. They let doctors match treatment to each tumor profile.
A biomarker signals a normal or abnormal process in the body. In cancer it can flag type and likely course. Some markers predict response to a given treatment. Others give outlook apart from any treatment choice. The review traces key milestones in biomarker science. Gains came from tumor biology and better test methods. Knowledge of the immune setting also moved the field. Profiling tumor material in blood adds new options. The authors look ahead to better patient outcomes from these tools.
Catalog record
| CREATOR | Passaro A, Al Bakir M, Hamilton EG, Diehn M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |